QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Avila, A. M. Articles by Kellar, K. J. Search for Related Content PubMed PubMed Citation Articles by Avila, A. M. Articles by Kellar, K. J.

Differential Regulation of Nicotinic Acetylcholine Receptors in PC12 Cells by Nicotine and Nerve Growth Factor

Department of Pharmacology, Georgetown University School of Medicine, Washington, DC

Neuronal nicotinic receptors in PC12 cells were measured by binding with [³H]epibatidine and in functional studies with agonist-stimulated ⁸⁶Rb⁺ efflux and [³H]norepinephrine release assays. Two subtypes of receptors labeled by [³H]epibatidine were found: one that was increased about 4-fold in cells grown for 2 to 4 days in the presence of nicotine and one that was increased 5-fold in cells grown for 2 to 4 days in the presence of nerve growth factor (NGF). The actions of the two treatments were superadditive, resulting in approximately a 13-fold increase in binding sites in cells grown in the combination of the two treatments. The pharmacology of the binding sites in the nicotine- and NGF-treated cells was compared with the pharmacology of defined 32 and 34 nicotinic acetylcholine receptor (nAChR) subtypes heterologously expressed in human embryonic kidney 293 cells. Nicotine treatment predominantly increased a receptor with characteristics of an 32 subtype, whereas the NGF treatment exclusively increased a receptor with characteristics of an 34 subtype. Nicotinic receptor-mediated function measured with the ⁸⁶Rb⁺ efflux assay was evident only in the NGF-treated cells, and it had a pharmacological profile that was, again, nearly identical to that of the heterologously expressed 34 receptor subtype. Receptor function measured with the [³H]norepinephrine release assay was measurable in both nicotine-treated and NGF-treated cells; however, cytisine-stimulated [³H]norepinephrine release indicated that nicotine treatment increased an nAChR containing 2 subunits, whereas NGF increased a receptor containing 4 subunits. NGF treatment increased mRNA only for 4 subunits in these cells, whereas nicotine treatment did not affect mRNA for any of the subunits measured. After withdrawal of the treatments, the receptors increased by nicotine were much less stable than those increased by NGF.

Address correspondence to: Dr. Kenneth J. Kellar, Department of Pharmacology, Georgetown University School of Medicine, 3900 Reservoir Rd. NW, Washington, DC 20057-2195. E-mail: kellark{at}georgetown.edu

This article has been cited by other articles:

				M. S. Hazari, J. H. Pan, and A. C. Myers Nerve growth factor acutely potentiates synaptic transmission in vitro and induces dendritic growth in vivo on adult neurons in airway parasympathetic ganglia Am J Physiol Lung Cell Mol Physiol, April 1, 2007; 292(4): L992 - L1001. [Abstract] [Full Text] [PDF]

				M. Ohtani, T. Oka, M. Badyuk, Y. Xiao, K. J. Kellar, and J. W. Daly Mouse beta-TC6 Insulinoma Cells: High Expression of Functional {alpha}3beta4 Nicotinic Receptors Mediating Membrane Potential, Intracellular Calcium, and Insulin Release Mol. Pharmacol., March 1, 2006; 69(3): 899 - 907. [Abstract] [Full Text] [PDF]

				Y. Xiao and K. J. Kellar The Comparative Pharmacology and Up-Regulation of Rat Neuronal Nicotinic Receptor Subtype Binding Sites Stably Expressed in Transfected Mammalian Cells J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 98 - 107. [Abstract] [Full Text] [PDF]